- Home
- GSBC vs SNY Comparison
GSBC vs SNY Comparison
Compare GSBC & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSBC
- SNY
- Stock Information
- Founded
- GSBC 1923
- SNY 1994
- Country
- GSBC United States
- SNY France
- Employees
- GSBC N/A
- SNY N/A
- Industry
- GSBC Major Banks
- SNY Biotechnology: Pharmaceutical Preparations
- Sector
- GSBC Finance
- SNY Health Care
- Exchange
- GSBC Nasdaq
- SNY Nasdaq
- Market Cap
- GSBC 676.3M
- SNY 113.4B
- IPO Year
- GSBC N/A
- SNY N/A
- Fundamental
- Price
- GSBC $62.67
- SNY $46.61
- Analyst Decision
- GSBC Hold
- SNY Buy
- Analyst Count
- GSBC 2
- SNY 4
- Target Price
- GSBC $60.50
- SNY $61.50
- AVG Volume (30 Days)
- GSBC 30.9K
- SNY 2.8M
- Earning Date
- GSBC 10-15-2025
- SNY 10-24-2025
- Dividend Yield
- GSBC 2.55%
- SNY 3.43%
- EPS Growth
- GSBC 17.24
- SNY 118.56
- EPS
- GSBC 5.86
- SNY 8.65
- Revenue
- GSBC $224,299,000.00
- SNY $53,714,621,258.00
- Revenue This Year
- GSBC N/A
- SNY $1.53
- Revenue Next Year
- GSBC N/A
- SNY $7.06
- P/E Ratio
- GSBC $10.70
- SNY $5.39
- Revenue Growth
- GSBC 4.82
- SNY 15.65
- 52 Week Low
- GSBC $47.58
- SNY $44.73
- 52 Week High
- GSBC $68.02
- SNY $60.12
- Technical
- Relative Strength Index (RSI)
- GSBC 54.99
- SNY 40.69
- Support Level
- GSBC $62.76
- SNY $46.79
- Resistance Level
- GSBC $63.81
- SNY $47.69
- Average True Range (ATR)
- GSBC 0.91
- SNY 0.68
- MACD
- GSBC -0.16
- SNY -0.26
- Stochastic Oscillator
- GSBC 13.83
- SNY 27.40
About GSBC Great Southern Bancorp Inc.
Great Southern Bancorp Inc is a bank holding company. It is principally engaged in the business of originating residential and commercial real estate loans, construction loans, commercial business loans, and consumer loans. The bank provides various services such as Business Banking, Merchant Services, Debit and Credit cards, Online Banking, Mobile Banking, VIP Banking, Overdraft Protection, and various other related services. It operates into a single segment which is Community Banking.
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.